NewsCura

Asia United Bank Corporation

Disclaimer: The research and recommendation below were generated by Claude Fable. Please treat this as one input for your own research — not as the sole basis for any decision to buy or sell a stock.

Last checked
Price
50.6000
Trading status
Normal
Recommendation
Buy (best bank fundamentals of the cycle; size small, thin liquidity)Buy
Committee call
Buy
Indices
MidCap

Analysis

AUB - Asia United Bank Corporation

One-line summary: a Rebisco/Ng family-controlled mid-size bank with the best fundamentals of any PH bank reviewed this cycle (roughly 20% ROE, 3.1% ROA, 0.4% NPL, 18.7% CET1) still trading at just 5.8x earnings, now raising its cash dividend and planning a 100% stock dividend and a capital stock increase, but the float is thin, the stock already trades above book, and there is no passive index bid to widen the discount further.

Snapshot
Reviewed July 19, 2026
Index membership PSE MidCap
Price at review P50.60 (July 17, 2026 close; last trading day before the weekend)
Recommendation Buy (quality-compounder pick; size positions small given thin liquidity)
Market cap ~P73.67B (1.456B shares)
Trailing P/E ~5.77x (TTM EPS P8.77)
Forward P/E Not available; no sell-side analyst coverage (typical for a MidCap-only PH bank); Q2 2026 results due August 13, 2026
Dividend P2.50/share for 2026 (P1.00 + P1.00 + P0.50 across three tranches), ~4.94% forward yield at P50.60
P/B ~1.04x (book value per share ~P48.65, Q1 2026 basis)
Capital (in place of D/E) CAR 19.3%, CET1 18.7% (Q1 2026), both far above BSP minimums of 10% / 6%

Net interest income, fees, and earnings trend

AUB's core engine is net interest income, which has compounded fast: P10.9B (2021), P12.9B (2022), P15.1B (2023), P16.8B (2024), P18.4B (2025), and P19.1B on a trailing-twelve-month basis through Q1 2026. Net income climbed from P4.05B (2021) to P6.27B (2022), P8.25B (2023), P11.34B (2024), and a record P12.71B (2025), roughly a tripling in four years. EPS followed the same path: P2.78 (2021), P4.30 (2022), P5.67 (2023), P7.79 (2024), P8.73 (2025).

Growth has decelerated recently, the same pattern seen across the PH banking sector this cycle. EPS growth ran 55% (2022), 32% (2023), and 37% (2024) before slowing to about 12% in 2025, and TTM EPS growth through Q1 2026 (P8.77) is only about 5% above the FY2025 base. Full-year 2025 total operating income rose 9% to P23.2B, with net interest income up 10% to P18.4B and other income (digital payments, remittances, fees) up 8% to P4.8B. Q1 2026 delivered a record quarterly net income of P3.2B, with net interest margin expanding to 5.3% (from 5.1% a year earlier) and the cost-to-income ratio improving to 30.4% (from 32.6%), a genuinely strong efficiency number for a PH bank of this size. Total loans grew 13% in 2025 (to P276B) and 9.4% year on year in Q1 2026, funded by CASA deposits that surged 25% in 2025 to 71% of total deposits, then further to 78% of total deposits by Q1 2026, an excellent and cheapening funding mix.

Asset quality, margins, and capital adequacy

Free cash flow is not a meaningful concept for a bank (deposit-taking and lending are the operating business, not investing activity to net against operations), so this section substitutes the metrics that describe a bank's health.

  • Asset quality: NPL ratio was 0.38% at end-2025 and 0.44% in Q1 2026, among the cleanest loan books on the exchange and far below both MBT (1.7-1.75%) and the industry average (roughly 3.2-3.4%). NPL coverage of 111-115% means reserves still exceed the (very small) bad-loan balance.
  • Net interest margin: 4.8% for full-year 2025, expanding to 5.3% in Q1 2026, well above MBT's 3.7%. This is the single biggest driver of AUB's ROA advantage over the bigger universal banks, and the biggest risk if BSP enters a sustained rate-cutting cycle.
  • Loan growth: total loans and receivables grew 13% in 2025 and 9.4% year on year in Q1 2026, concentrated in commercial lending, with provisioning rising modestly (P331M in Q1 2026) alongside the growth, a normal and expected pattern.
  • Capital adequacy: CAR and CET1 stood at 19.1% and 18.4% at end-2025, then improved further to 19.3% and 18.7% in Q1 2026, comfortably the strongest capital position of any bank reviewed this cycle (versus MBT's 14.9%/14.2%) and roughly double the BSP minimums. This is a bank retaining far more capital than it currently needs, which cuts both ways: very safe, but also a sign that payout could be higher without stressing the balance sheet.
  • Deposits: total deposit liabilities of P335.5B at end-Q1 2026 (+8.9% year on year), with CASA at 78% of the total, an unusually cheap and sticky funding base for a mid-size bank.

Dividend sustainability

The per-share cash dividend has kept climbing: P1.165 (2024: P0.665 + P0.50), P2.00 (2025: P1.00 + P1.00), and now P2.50 declared for 2026, tracking the strong EPS growth over the same period (P7.79 to P8.73). The 2026 dividend moved from two tranches to three: P1.00/share (record July 10, paid July 30, already paid), P1.00/share (record September 14, payable September 30), and P0.50/share (record December 2, payable December 18). That is a real increase in the run rate, not a repeat of last year's pattern the page previously assumed. Against 2025 EPS of P8.73, the payout ratio rises to roughly 28.6% (up from about 23% the prior year), still low in absolute terms but a genuine step toward the buy-trigger scenario noted in the July 10 review (management using excess capital to raise payout). Combined with CET1 still at 18.7%, comfortably above what is needed to fund current loan growth, the bank continues to retain most of its profit even after the raise. The dividend itself looks extremely safe (well covered, backed by 0.4% NPL and capital ratios nearly double the industry norm), and the new 4.83% yield at P51.80 closes some of the gap to MBT (~7.5%) or CBC, though the AUB thesis remains earnings growth and quality first, yield second.

Separately, the board also proposed a 100% stock dividend (doubling the share count), which is a different corporate action from the cash dividend above and should not be read as additional income: it is a bookkeeping split tied to a capital stock increase (see Capital allocation), pending an August 28, 2026 shareholder vote.

ROE

ROE climbed from 11.11% (2021) to 16.12% (2022), 18.61% (2023), and peaked at 21.18% (2024), before easing to 19.97% (2025) and 19.30% on a trailing basis through Q1 2026. ROA followed the same arc: 1.28% (2021), 1.91% (2022), 2.38% (2023), 3.06% (2024), 3.10% (2025), 3.17% currently. Both figures are the strongest of any PH bank reviewed this cycle (MBT's ROE plateaued at 12-13%, with ROA around 1.3-1.5%), and critically this is not a leverage story: capital ratios are nearly double MBT's and far above regulatory minimums, so the high ROE reflects a genuinely more profitable underlying banking franchise (wider margins, lower credit costs, better efficiency), not a thin equity base amplifying returns.

Capital allocation

Capital is being split three ways in practice: funding loan growth (13% in 2025), building an already-outsized capital buffer (CET1 18.7%, nearly double the regulatory minimum), and a modest but now-rising dividend (28.6% payout, up from 23%). There are no buybacks and no acquisitions in the recent record.

The new development since the July 10, 2026 review is a board-approved plan to raise authorized capital stock from P14.70B to P72.5B, paired with a proposed 100% stock dividend that would double the share count, both subject to shareholder approval at a special stockholders' meeting on August 28, 2026 (hybrid format; shareholders on record as of July 30, 2026 are eligible to vote). Per the company's Investor Relations officer, the stock dividend exists specifically to satisfy a 25% subscription requirement tied to the capital increase, and management describes the larger authorized capital as providing "flexibility for future corporate actions and accommodates future equity issuances to existing or new investors." Read plainly: this is an accounting and structural move, doubling the share count and roughly halving book value and EPS per share without changing total equity, CET1, or ROE by itself, but it does open the door to a future capital raise or share issuance to new investors, which would be genuinely dilutive if it happens below fair value. Nothing in the disclosures so far describes a concrete raise, only that the option is being created; this is worth tracking through the August 28 vote and any follow-on disclosure.

There is also a board leadership change to correct from the July 10 review: as of the July 2026 disclosures, Abraham T. Co (a career bank executive, previously AUB's Vice Chairman and CEO, and chairman before 2023) has returned to the chairman role, replacing Jonathan Ng, who had chaired since July 2023. Jonathan Ng is a Rebisco/Ng family member; Abraham Co is a long-serving AUB insider but not a Ng family member, so this reads as a normal board rotation among long-tenured insiders rather than a change in who controls the bank.

One new item since the July 12 review: AUB extended a P5B (roughly $81M) wholesale credit facility to Atome Philippines, a buy-now-pay-later fintech backed by SoftBank Vision Fund 2 and Warburg Pincus, to fund Atome's PayLater card expansion. This is ordinary commercial lending activity (consistent with the 9.4% year-on-year loan growth already noted), not a new business line or equity stake for AUB, and is small relative to the P276B loan book. Separately, AUB announced free InstaPay/PESONet transfers via its digital channels starting July 20, 2026, a retail customer-acquisition promo rather than a material earnings item. A mid-level SVP heading the Treasury FX trading desk resigned effective July 31, 2026, a routine personnel change with no board-level implications.

Ownership itself remains tightly concentrated in the Rebisco Group/Ng family. As of mid-2025, the largest holders were Kuo Yu Philippines Holdings Corporation (18.54%), Ciudad Kuvera Investments Corporation (15.00%), Lambda Holdings Corporation (14.84%), and Republic Biscuit Corporation, the Rebisco flagship (14.51%), together more than 62% of shares outstanding, all under the Ng family's effective control, on top of direct family holdings (Jacob Ng, youngest son of founder Jacinto L. Ng Sr., has built a stake reported around 15% in his own name). Jacob Ng serves as an EVP overseeing branch banking and digital transformation. This is a family-run bank in the fullest sense: the same family that owns Rebisco (the biscuit and snack conglomerate) controls the bank's board and day-to-day strategy, regardless of which insider holds the chairman title. That concentration means real public float is thin, likely well under a third of shares outstanding once family and affiliated holding companies are excluded, which is the direct cause of the low trading volume discussed below. It is a patient-capital, low-drama ownership structure so far (no related-party lending scandals surfaced in this research), but minority shareholders have essentially no influence over payout policy, the pending capital increase, or strategic direction.

On the growth side, AUB's HelloMoney e-wallet is the most visible non-traditional-banking initiative: it had set a target of 6.5 million users by 2026 as of an October 2025 announcement, but had already reached nearly 9 million users by end-2025, ahead of schedule. Partnerships with Singlife Philippines and the Social Security System (exposing HelloMoney to SSS's roughly 40 million members for benefits, loans, and pensions) and connectivity to the Alipay+ network (China and roughly 60 other countries) are expanding its reach, and a 2026 rollout of "AUB PayMate Business" targets MSME invoicing and inventory financing. Management has also flagged a generative-AI and digitalization push as a 2026 growth theme in PH business press. HelloMoney's user growth is a genuine fee-income and CASA-funding tailwind (it likely contributes to the CASA ratio's rapid rise to 78%), though it does not yet appear as a standalone disclosed profit center.

Verdict at P50.60 (July 19, 2026)

Buy, unchanged from July 12. The fundamentals driving the call have not moved: Q2 2026 results are not due until August 13, 2026, so the last hard data point remains Q1 2026 (~19-20% ROE, ~3.1% ROA, 0.44% NPL, 18.7% CET1). The only change since last week is the price, which drifted down from P51.80 to P50.60 (about 2.3%) on no new fundamental news, pulling the trailing multiple to 5.77x and the P/B to 1.04x, a small improvement in entry terms rather than a deterioration in the business.

That modest pullback is worth noting against the buy trigger below: price is still above book value (~P48.65), so the "add on weakness toward or below book" condition has not fired, but the gap has narrowed slightly. The August 28, 2026 shareholder vote on the capital stock increase (to P72.5B) and 100% stock dividend remains the key date to watch; nothing concrete on an actual equity issuance has been disclosed yet, so the dilution risk stays a "watch" item, not a "sell" item.

The week's other news is incremental, not thesis-changing: a P5B wholesale facility to Atome Philippines is ordinary commercial loan growth, a free InstaPay/PESONet transfer promo is a retail acquisition tactic, and a mid-level Treasury FX SVP's resignation is routine. None of it touches the core thesis (underwriting quality, funding cost, capital strength) one way or the other.

The bigger practical risk remains liquidity, not fundamentals. Average daily volume has stayed around 56,000 shares, roughly P2.9 million in value traded per day, on a P73.67B market cap company. That is a function of the tight Rebisco/Ng family and affiliated-holding-company ownership (over 62% concentrated in four entities alone, plus direct family stakes), which leaves genuine public float thin. AUB is MidCap-only (not in the PSEi or MSCI Philippines), so there is no passive index-fund bid to support the stock or absorb selling, and any real position size will take time to build or exit without moving the price. The low beta (0.10) likely reflects stale, thin pricing rather than genuinely low volatility, and should not be read as a safety signal.

What would change the call:

  • Buy trigger (add on weakness): price pulls back toward or below book value (~P48-49) while NPL stays under 1% and CET1 stays above 15%, giving a genuine margin-of-safety entry on top of the quality; or the payout ratio is raised further (toward 30-40%, up from the current 28.6%) without hurting capital ratios.
  • Sell trigger: NPL ratio rises above roughly 1.5% (still below the industry average but a real deterioration from best-in-class), ROE falls out of the high teens (removing the justification for trading above book), a related-party or Rebisco-group-linked lending issue surfaces given the tight family control, CET1 is drawn down sharply (below roughly 12%) to fund a large acquisition or family-related transaction without a clear return case, or the August 28, 2026 vote results in new shares being issued to outside or affiliated investors at a price that dilutes existing minority holders.

Neither trigger has fired since the July 12 review. This is a name to accumulate patiently and hold for the quality of the underlying franchise, not to trade, given how thin the daily volume is. Analysis, not financial advice.

Committee review (July 19, 2026)

Five investor lenses judged the facts above independently, each strictly inside its own framework, run as parallel subagents fed only the page's facts.

Lens Signal Confidence Core argument
Ben Graham Bullish 66 A Graham-number estimate (sqrt(22.5 x P8.77 EPS x ~P48.65 BVPS) ≈ P98) sits nearly double the P50.60 price, and P/B of 1.04x with P/E of 5.77x gives real margin of safety, with CAR 19.3%/CET1 18.7% far above regulatory minimums; the weak leg is earnings history, only 5-6 documented years with no downturn tested, so decade-long stability can't be confirmed even though price and balance sheet are strong.
Warren Buffett Bullish 58 A 71-78% CASA ratio funding a 19.97% ROE and 4.8-5.3% NIM without leverage tricks (CET1 18.7%, nearly double the regulatory floor) points to real moat economics, priced far below what that return on capital deserves at 5.77x earnings and 1.04x book; docked for only 5-6 years of untested earnings history, decelerating growth (55% to ~5% TTM), and the vague capital-increase/stock-dividend proposal that could be dilution dressed as "flexibility."
Michael Burry Bullish 58 Priced at 5.77x earnings and 1.04x book as if the balance sheet were fragile, but CET1 18.7% and 111-115% NPL coverage say otherwise, with no passive-index bid propping the price; the untested credit cycle and vague "flexibility" language around doubling authorized capital are the kind of unverified management-speak that warrant discounting the multiple, not avoiding the position.
Nassim Taleb Bearish 58 Banking is inherently short-volatility, and AUB has only 5-6 years of history with zero exposure to a real credit downturn, while loan growth (13% in 2025, still 9.4% YoY) concentrates further into untested commercial exposure even as EPS growth decelerates from 55% to 5%; ~P2.9M average daily turnover traps minority holders in a tail event, and the unpriced August 28 capital vote is asymmetric optionality for management against undisclosed dilution risk for outside shareholders.
Stanley Druckenmiller Bearish 58 The only two dated catalysts, the August 13 Q2 earnings and the August 28 vote to double authorized capital plus a 100% stock dividend, skew toward dilution risk rather than a clean upside trigger, and the stock is already drifting down (P51.80 to P50.60) pre-emptively pricing that uncertainty; with ~P2.9M average daily turnover there is no way to size a position that exits cleanly around either event, so strong ROE and NIM don't matter without a clean catalyst.

Conferred call: Buy (3 bullish, 2 bearish). This matches the page's Recommendation, though the split narrowed from last week (was 3 bullish, 1 bearish, 1 neutral): Druckenmiller flipped from neutral to bearish now that both remaining 2026 catalysts (Q2 earnings, the capital vote) read as dilution risk rather than upside, and the stock's modest pullback is being read as the market pricing that in rather than as a buying opportunity. Taleb and Druckenmiller both still flag the pending capital increase and stock dividend as an unresolved structural risk (dilution optionality, thin liquidity) rather than a pure positive, the same caution raised in the Capital allocation section above; the bullish majority is grounded in balance-sheet quality (CET1, NPL, ROE) that neither dissenting lens disputes. Checked against the trading rulebook: no new catalyst has fired this week, so this stays a hold-and-accumulate setup rather than a fresh trade signal, and the stock is not at a low, so the "cheap at the lows" trap warning doesn't apply.

Review history

Date Price Recommendation
July 10, 2026 51.50 Buy (quality-compounder pick; size positions small given thin liquidity)
July 12, 2026 51.80 Buy (quality-compounder pick; size positions small given thin liquidity)
July 19, 2026 50.60 Buy (quality-compounder pick; size positions small given thin liquidity)

Sources